Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Fountainhead Capital Management Files Update on Vycor Medical Inc (VYCO) Holding

Activist shareholders continue to be closely-monitored and imitated by investors, given their ability to affect positive change at companies. Whether it be by pressuring companies to set loose underperforming divisions, pushing for change on the company’s Board, or advocating for more of the company’s profits to be distributed to shareholders in the form of share buybacks and/or dividend payments, activist investors know how to move the needle in the right direction. Embedded below and on the following pages is the latest 13D activist filing issued by Fountainhead Capital Management Ltd, in relation to its position in Vycor Medical Inc (OTCMKTS:VYCO). Check it out to see the investor’s latest ownership stake in the stock, which amounts to nearly 70% of the issuer’s series D convertible stock.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Fountainhead Capital Management Limited 181,994 0 181,994 0 181,994 69.68%

Page 1 of 4 SEC Filing



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
SCHEDULE 13D/A
(Rule 13d-101)
Third Amendment
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
 
VYCOR MEDICAL, INC.
(Name of Issuer)
 
7% SERIES D CONVERTIBLE REDEEMABLE PREFERRED STOCK, PAR VALUE $0.0001
(Title of Class of Securities)
 
n/a
(CUSIP Number)
 
Fountainhead Capital Management Limited
1 Portman House, Hue Street
St. Helier, Jersey, Channel Islands JE4 5RP
+44 (0)1534 630112
 
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
February 5, 2016
(Date of Event which Requires Filing Statement on Schedule 13D)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box ¨.
 


Follow Vycor Medical Inc (OTCMKTS:VYCO)
Trade (OTCMKTS:VYCO) Now!
Loading...